Open original FDA record ↗Recall record
- FDA identifier
- Z-2576-2021
- Company in FDA record
- Abbott Molecular, Inc.
- FDA record creation date
- Sep 27, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for Vysis CLL FISH Probe Kits not detecting 13q deletions in known positive patient samples.
Source facts
- Action
- On about 08/04/2021, Abbott Molecular notified consignees via FedEx with letter titled "Urgent Field Safety Notice Molecular Diagnostics at Abbott Product: Vysis CLL FISH Probe." The letter instructed customers to discontinue use of the affected lots, discard any remaining kits on hand, complete and return the customer reply form, and notify impacted customers if the affected lots have been further distributed. Additional instructions included to review the recall notification information with your Medical Director or physicians as appropriate and retain the communication for future reference. Review patient results generated with the impacted lots and determine if retesting is required taking patient medical history and previous treatment into consideration.
- Initiated
- 2021-08-04
- Root cause
- Under Investigation by firm
- Terminated
- 2023-05-31
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of AZ, CA, FL, GA, IL, IN, KY, MI, MN, MA, NC, NJ, NM, NY, OH, PA, TN, TX, UT, VA, VT, WA, WI and the countries of Australia, Belgium, Brazil, Canada, China, Costa Rica, Czech Republic, Estonia, Germany, Hong Kong, Israel, Italy, Kazakhstan, Netherlands, Philippines, Poland, Saudi Arabia, Slovenia, South Africa, South Korea, Spain, United Kingdom, Uruguay.
- Recall number
- Z-2576-2021
- Recall status
- Terminated
- CDRH record ID
- 189008
- FDA record created
- 2021-09-27
- Recall event number
- 88565